Dr. Stirewalt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-288-1000- Is this information wrong?
Education & Training
University of WashingtonFellowship, Medical Oncology, 1995 - 1999
University of North Carolina at Chapel Hill School of MedicineClass of 1992, MD
Certifications & Licensure
WA State Medical License 1996 - 2025
NC State Medical License 1995 - 1998- American Board of Internal Medicine Medical Oncology
Clinical Trials
- S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid Leukemia Start of enrollment: 2008 Nov 01
- S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin Start of enrollment: 2011 Dec 01
Publications & Presentations
PubMed
- R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription-Replication Conflicts.Liu, Z., Sinha, S., Bannister, M., Song, A., Arriaga-Gomez, E., McKeeken, A., Bonner, E., Hanson, B., Sarchi, M., Takashima, K., Zong, D., Corral, V., Nguyen, E., Yoo,...> ;Cancer Research. 2024 Feb 15
- Discovery of U2AF1 neoantigens in myeloid neoplasms.Lok, J., Black, R., Foster, K., Cummings, C., Woodward, K., Monahan, T., Rongvaux, A., Biernacki, M., Oehler, V., Stirewalt, D., Wu, D., Deeg, H., Bleakley, M.> ;Journal for Immunotherapy of Cancer. 2023 Dec 12
- 4 citationsCharacteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis.Sara Zarnegar-Lumley, Todd A Alonzo, Robert B Gerbing, Megan Othus, Zhuoxin Sun, Rhonda E Ries, Jim Wang, Amanda Leonti, Matthew A Kutny, Fabiana Ostronoff, Jerald P R...> ;Blood Advances. 2023 Oct 10
- Join now to see all
Journal Articles
- Second Cycle Remission Achievement with 7+3 and Survival in Adults with Newly Diagnosed Acute Myeloid Leukemia: Analysis of Recent SWOG TrialsBrent L Wood, Roland B Walter, John E Godwin, James K Weick, Elihu H Estey, Derek L Stirewalt, Frederick R Appelbaum, Nature
Grant Support
- Discovery And Optimization Of AML Prognostic BiomarkersNational Cancer Institute2012
- IRF8 As A Biomarker Of Aging, Malignant Transformation, And AML PrognosisNational Cancer Institute2010–2011
- Quantitative Rt/Pcr-Based Radiation DosimetryNational Institute Of Allergy And Infectious Diseases2005–2009
- Examination Of FLT3 Mutations In Acute Myeloid LeukemiaNational Cancer Institute2002–2006
Hospital Affiliations
Fred Hutchinson Cancer CenterSeattle, Washington
UW Medicine/University of Washington Medical CenterSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
